Russia has a huge potential for clinical trials to achieve fast patient recruitment and a low drop-out rate. However, a rapidly changing regulatory environment and continuous issues with supply chain and logistics are holding up clinical study sponsors to utilize all benefits of the region.
New clinical trial regulations and restrictions are introduced almost every quarter and together with lengthy custom clearance process and poor road infrastructure, this adds to unpredicted and significant delays.
Join this webinar where you can listen to a local expert partner who has a deep knowledge of actual clinical trials regulations and legislation. Understanding the realities and requirements of the import/export process is a critical factor in the success of trials conducted in Russia.
The perfect provider would also support you in other European countries and integrate your clinical data from Russia into single harmonized database with results collected from the whole trial.
Register now to learn more.
Tomasz Anyszek, MD, PhD, EurClinChem,
Synevo Central Labs Director
Tomasz Anyszek is director of Synevo Central Lab since 2009 and is responsible for clinical trials operations in more than 50 laboratories in Central and Eastern Europe. Dr. Anyszek started his career with Virtual Central Laboratory, Netherlands in 2000 (Covance VCL since 2003) and his experience also includes the coordination of 16 regional Covance partner laboratories in Europe. During this period he performed about 200 audits in clinical laboratories. Dr. Anyszek holds his PhD from Jagiellonian University, Poland. Prior to his business career, he taught clinical biochemistry and laboratory medicine at the Jagiellonian University medical faculty. Dr. Anyszek has authored more than 20 scientific publications and co-authored several books and monographies in the clinical chemistry and laboratory medicine area.
Michal Dysko,
Head of Business Development
Michal Dysko has more than 10 years of experience in the clinical research industry from the clinical trial services provider perspective.
Michal is Head of Business Development at Synevo Central Labs, the largest wholly-owned and fully-harmonized network of central laboratories in Europe dedicated exclusively to support clinical trials. Michal has joined Synevo Central Labs in 2008 and is responsible for sales and marketing operations of the whole network.
Before joining Synevo Central Labs, he has been Sales and Marketing Director at Kiecana Clinical Research, the Central and Eastern European CRO headquartered in Poland, since 2003. In 2005, he has joined Europharm Research, UK based CRO, as Executive Director, Business Development. Since 2006 to 2008 he has been Managing Director at privately-held consulting company in the clinical research field.
Michal has obtained his MBA degree from the University of Quebec at Montreal and the Warsaw School of Economics in 2003.
- To recognise the potential of the clinical trials market in Russia
- To identify the key challenges of the industry
- To understand the best practices to overcome these challenges
- Decentralized central laboratory services model to support multinational clinical studies
- Clinical Operations Director
- Head Clinical Development
- Head Clinical Research
- Clinical Outsourcing Manager
- Head Outsourcing and vendor Management
- Clinical Trial Manager
- Clinical Study Manager
- Medical Director
- Chief Scientific Officer
